EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Role of Genetic and Epigenetic Modifications in the Progression of Hepatocellular Carcinoma in Chronic HCV Patients

Anum Syyam, Hira Raheem Akbar, Zuzana Macek Jilkova, Samia Afzal

Livers · 20.02.2023 · 3 (1) · 82-92

DOI: 10.3390/livers3010008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Livers, online erschienen am 20.02.2023. Verfasst von Anum Syyam und 3 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HEC Pakistan.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Globally, hepatocellular carcinoma (HCC) is a significant cause of mortality and morbidity among chronically infected HCV patients. It is established that HCV is a primary risk factor for HCC progression. The treatment of HCV infection has been transformed by the introduction of DAAs with high rates of virological clearance. The reduction in cirrhosis-related consequences, particularly HCC, is the long-term objective of DAAs therapy for HCV. Although the risk of developing HCC is decreased in HCV patients who achieve a disease-sustaining virological response, these patients are nevertheless at risk, especially those with severe fibrosis and cirrhosis. Previous studies have shown that HCV induce several mechanisms of hepatocarcinogenesis in the host’s hepatic micro- and macro-environment, which leads to HCC progression. In an HCV-altered environment, compensatory liver regeneration favors chromosomal instability and irreversible alterations, which encourage hepatocyte neoplastic transformation and the development of malignant clones. These mechanisms involve a series of genetic and epigenetic modifications including host genetic factors, dysregulation of several signaling pathways, histone, and DNA modifications including methylation and acetylation. This review highlights the genetic and epigenetic factors that lead to the development of HCC in chronic HCV-infected individuals and can be targeted for earlier HCC diagnosis and prevention.

Förderung

  • HEC Pakistan

Zitieren

APA

Syyam, A., Akbar, H. R., Jilkova, Z. M., & Afzal, S. (2023). Role of Genetic and Epigenetic Modifications in the Progression of Hepatocellular Carcinoma in Chronic HCV Patients. Livers, 3(1), 82-92. https://doi.org/10.3390/livers3010008

Vancouver

Syyam A, Akbar HR, Jilkova ZM, Afzal S. Role of Genetic and Epigenetic Modifications in the Progression of Hepatocellular Carcinoma in Chronic HCV Patients. Livers. 2023;3(1):82-92. doi:10.3390/livers3010008

BibTeX
@article{Syyam2023,
  author = {Syyam, Anum and Akbar, Hira Raheem and Jilkova, Zuzana Macek and Afzal, Samia},
  title = {Role of Genetic and Epigenetic Modifications in the Progression of Hepatocellular Carcinoma in Chronic HCV Patients},
  journal = {Livers},
  year = {2023},
  volume = {3},
  number = {1},
  pages = {82--92},
  doi = {10.3390/livers3010008}
}
Kostenlos starten →